{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:51:49Z","timestamp":1790779909874,"version":"4.1.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:title>AbstractAbstract<\/jats:title>\n                  <jats:p>\n                    In conscious rats, administration of the 5-HT\n                    <jats:sub>1A<\/jats:sub>\n                    receptor agonist, befiradol, reversed fentanyl-induced respiratory depression, but also antinociception, and caused abnormal behaviors that may limit clinical efficacy.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      There is an unmet clinical need to develop a pharmacological therapy to counter opioid-induced respiratory depression without interfering with analgesia or behavior. Several studies have demonstrated that 5-HT\n                      <jats:sub>1A<\/jats:sub>\n                      receptor agonists alleviate opioid-induced respiratory depression in rodent models. However, there are conflicting reports regarding their effects on analgesia due in part to varied agonist receptor selectivity and presence of anesthesia. Therefore the authors performed a study in rats with befiradol (F13640 and NLX-112), a highly selective 5-HT\n                      <jats:sub>1A<\/jats:sub>\n                      receptor agonist without anesthesia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Respiratory neural discharge was measured using\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      preparations. Plethysmographic recording, nociception testing, and righting reflex were used to examine respiratory ventilation, analgesia, and sedation, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Befiradol (0.2 mg\/kg, n = 6) reduced fentanyl-induced respiratory depression (53.7 \u00b1 5.7% of control minute ventilation 4 min after befiradol\n                      <jats:italic toggle=\"yes\">vs<\/jats:italic>\n                      . saline 18.7 \u00b1 2.2% of control, n = 9;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), duration of analgesia (90.4 \u00b1 11.6 min\n                      <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                      saline 130.5 \u00b1 7.8 min;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.011), duration of sedation (39.8 \u00b1 4 min\n                      <jats:italic toggle=\"yes\">vs<\/jats:italic>\n                      . saline 58 \u00b1 4.4 min;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.013); and induced baseline hyperventilation, hyperalgesia, and \u201cbehavioral syndrome\u201d in nonsedated rats. Further, the befiradol-induced alleviation of opioid-induced respiratory depression involves sites or mechanisms not functioning\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      brainstem\u2013spinal cord and medullary slice preparations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The reversal of opioid-induced respiratory depression and sedation by befiradol in adult rats was robust, whereas involved mechanisms are unclear. However, there were adverse concomitant decreases in fentanyl-induced analgesia and altered baseline ventilation, nociception, and behavior.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aln.0000000000000490","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T11:37:39Z","timestamp":1413286659000},"page":"424-434","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":55,"title":["5-HT1A Receptor Agonist Befiradol Reduces Fentanyl-induced Respiratory Depression, Analgesia, and Sedation in Rats"],"prefix":"10.1097","volume":"122","author":[{"given":"Jun","family":"Ren","sequence":"first","affiliation":[{"name":"From the Department of Physiology, Neuroscience, and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada (J.R., X.D., J.J.G.); and the Alberta Innovates Health Sciences Foundation, Edmonton, Alberta, Canada (J.J.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Ding","sequence":"additional","affiliation":[{"name":"From the Department of Physiology, Neuroscience, and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada (J.R., X.D., J.J.G.); and the Alberta Innovates Health Sciences Foundation, Edmonton, Alberta, Canada (J.J.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Greer","sequence":"additional","affiliation":[{"name":"From the Department of Physiology, Neuroscience, and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada (J.R., X.D., J.J.G.); and the Alberta Innovates Health Sciences Foundation, Edmonton, Alberta, Canada (J.J.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20241223","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2146\/news070035","article-title":"Prevention of respiratory depression becomes safety foundation\u2019s new goal.","volume":"64","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"R2-20241223","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1152\/jn.1992.67.4.996","article-title":"Generation of respiratory and locomotor patterns by an in vitro brainstem\u2013spinal cord fetal rat preparation.","volume":"67","year":"1992","journal-title":"J Neurophysiol"},{"key":"R3-20241223","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.1683005","article-title":"Pre-B\u00f6tzinger complex: A brainstem region that may generate respiratory rhythm in mammals.","volume":"254","year":"1991","journal-title":"Science"},{"key":"R4-20241223","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1152\/jn.1993.70.4.1497","article-title":"Generation and transmission of respiratory oscillations in medullary slices: Role of excitatory amino acids.","volume":"70","year":"1993","journal-title":"J Neurophysiol"},{"issue":"5 Pt 2","key":"R5-20241223","first-page":"4046","article-title":"Modulation of neural network activity in vitro by cyclothiazide, a drug that blocks desensitization of AMPA receptors.","volume":"15","year":"1995","journal-title":"J Neurosci"},{"key":"R6-20241223","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.200606-778OC","article-title":"Ampakines alleviate respiratory depression in rats.","volume":"174","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20241223","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e31819faa2a","article-title":"Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats.","volume":"110","year":"2009","journal-title":"Anesthesiology"},{"key":"R8-20241223","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1152\/japplphysiol.00752.2012","article-title":"Respiratory depression in rats induced by alcohol and barbiturate and alleviation by ampakine CX717.","volume":"113","year":"2012","journal-title":"J Appl Physiol"},{"key":"R9-20241223","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/ALN.0b013e318291079c","article-title":"Coadministration of the AMPAKINE CX717 with propofol reduces respiratory depression and fatal apneas.","volume":"118","year":"2013","journal-title":"Anesthesiology"},{"key":"R10-20241223","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.clpt.6100018","article-title":"The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.","volume":"81","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R11-20241223","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0022-3565(24)35342-X","article-title":"Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors.","volume":"292","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-20241223","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1213\/ane.0b013e318198f828","article-title":"The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.","volume":"108","year":"2009","journal-title":"Anesth Analg"},{"key":"R13-20241223","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1213\/ANE.0b013e3181eac011","article-title":"Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats.","volume":"111","year":"2010","journal-title":"Anesth Analg"},{"key":"R14-20241223","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ALN.0b013e31823d08fa","article-title":"Selective 5-HT(1A)-R-agonist repinotan prevents remifentanil-induced ventilatory depression and prolongs antinociception.","volume":"116","year":"2012","journal-title":"Anesthesiology"},{"key":"R15-20241223","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2013.02.009","article-title":"Effects of cholinesterase inhibitors and serotonin-1A receptor agonists on morphine-induced ventilatory depression and antinociception in rats.","volume":"703","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"R16-20241223","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3940(85)80120-8","article-title":"The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphine.","volume":"54","year":"1985","journal-title":"Neurosci Lett"},{"key":"R17-20241223","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0028-3908(90)90020-R","article-title":"Attenuation of opioid induced antinociception by 5-HT1A partial agonists in the rat.","volume":"29","year":"1990","journal-title":"Neuropharmacology"},{"key":"R18-20241223","first-page":"983","article-title":"5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.","volume":"256","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"R19-20241223","first-page":"993","article-title":"5-hydroxytryptamine (HT)1A receptors and the tail-flick response. III. Structurally diverse 5-HT1A partial agonists attenuate mu- but not kappa-opioid antinociception in mice and rats.","volume":"256","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-20241223","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3565(25)38088-2","article-title":"Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.","volume":"265","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"R21-20241223","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF02246409","article-title":"The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure.","volume":"126","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"R22-20241223","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0304-3940(89)90822-7","article-title":"Apparent hyperalgesic action of the 5-HT1A agonist, 8-OH-DPAT, in the rat reflects induction of spontaneous tail-flicks.","volume":"107","year":"1989","journal-title":"Neurosci Lett"},{"key":"R23-20241223","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0028-3908(02)00119-3","article-title":"Large-amplitude 5-HT1A receptor activation: A new mechanism of profound, central analgesia.","volume":"43","year":"2002","journal-title":"Neuropharmacology"},{"key":"R24-20241223","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.09.003","article-title":"The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain.","volume":"523","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R25-20241223","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.neuropharm.2008.09.004","article-title":"Region-specific changes in 5-HT1A agonist-induced extracellular signal-regulated kinases \u00bd phosphorylation in rat brain: A quantitative ELISA study.","volume":"56","year":"2009","journal-title":"Neuropharmacology"},{"key":"R26-20241223","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00213-011-2569-9","article-title":"In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.","volume":"221","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"R27-20241223","first-page":"40","article-title":"5-HT(1A) receptor activation: New molecular and neuroadaptive mechanisms of pain relief.","volume":"7","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"R28-20241223","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1152\/jn.1990.64.4.1149","article-title":"Neural mechanisms generating respiratory pattern in mammalian brain stem\u2013spinal cord in vitro. I. Spatiotemporal patterns of motor and medullary neuron activity.","volume":"64","year":"1990","journal-title":"J Neurophysiol"},{"key":"R29-20241223","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1476-5381.1978.tb17290.x","article-title":"The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.","volume":"64","year":"1978","journal-title":"Br J Pharmacol"},{"key":"R30-20241223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resp.2011.10.002","article-title":"Isolated in vitro brainstem\u2013spinal cord preparations remain important tools in respiratory neurobiology.","volume":"180","year":"2012","journal-title":"Respir Physiol Neurobiol"},{"key":"R31-20241223","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.resp.2013.01.011","article-title":"The rhythmic, transverse medullary slice preparation in respiratory neurobiology: Contributions and caveats.","volume":"186","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"R32-20241223","first-page":"845","article-title":"Opioid depression of respiration in neonatal rats.","volume":"485(Pt 3)","year":"1995","journal-title":"J Physiol"},{"key":"R33-20241223","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s004240050543","article-title":"Modulation of respiratory rhythm by 5-HT in the brainstem\u2013spinal cord preparation from newborn rat.","volume":"435","year":"1998","journal-title":"Pflugers Arch"},{"key":"R34-20241223","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0306-4522(02)00540-7","article-title":"Serotonergic modulation of respiratory motoneurons and interneurons in brainstem slices of perinatal rats.","volume":"115","year":"2002","journal-title":"Neuroscience"},{"key":"R35-20241223","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1523\/JNEUROSCI.0864-13.2014","article-title":"Dual effects of 5-HT(1a) receptor activation on breathing in neonatal mice.","volume":"34","year":"2014","journal-title":"J Neurosci"},{"key":"R36-20241223","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1152\/japplphysiol.01270.2009","article-title":"The role of medullary serotonin (5-HT) neurons in respiratory control: Contributions to eupneic ventilation, CO2 chemoreception, and thermoregulation.","volume":"108","year":"2010","journal-title":"J Appl Physiol (1985)"},{"key":"R37-20241223","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1152\/japplphysiol.00071.2007","article-title":"Persistence of eupnea and gasping following blockade of both serotonin type 1 and 2 receptors in the in situ juvenile rat preparation.","volume":"103","year":"2007","journal-title":"J Appl Physiol (1985)"},{"key":"R38-20241223","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1152\/japplphysiol.91461.2008","article-title":"Genesis of gasping is independent of levels of serotonin in the Pet-1 knockout mouse.","volume":"107","year":"2009","journal-title":"J Appl Physiol (1985)"},{"key":"R39-20241223","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1152\/japplphysiol.00889.2013","article-title":"A selective 5-HT1a receptor agonist improves respiration in a mouse model of Rett syndrome.","volume":"115","year":"2013","journal-title":"J Appl Physiol (1985)"},{"key":"R40-20241223","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.1084674","article-title":"5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia.","volume":"301","year":"2003","journal-title":"Science"},{"key":"R41-20241223","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.clpt.2005.05.010","article-title":"The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.","volume":"78","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R42-20241223","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration.","volume":"100","year":"2008","journal-title":"Br J Anaesth"},{"key":"R43-20241223","first-page":"1292","article-title":"A critical site in the medulla mediates opioid-induced respiratory depression.","volume":"31","year":"2011","journal-title":"J Neurosci"},{"key":"R44-20241223","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function.","volume":"38","year":"1999","journal-title":"Neuropharmacology"},{"key":"R45-20241223","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.molmed.2003.10.010","article-title":"Serotonin receptors: Guardians of stable breathing.","volume":"9","year":"2003","journal-title":"Trends Mol Med"},{"key":"R46-20241223","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1523\/JNEUROSCI.17-11-04473.1997","article-title":"Postnatal development of serotonergic innervation, 5-HT1A receptor expression, and 5-HT responses in rat motoneurons.","volume":"17","year":"1997","journal-title":"J Neurosci"},{"key":"R47-20241223","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1113\/jphysiol.1994.sp020116","article-title":"5-HT-1A receptor-mediated modulation of medullary expiratory neurones in the cat.","volume":"476","year":"1994","journal-title":"J Physiol"},{"key":"R48-20241223","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1172\/JCI43029","article-title":"Serotonin receptor 1A-modulated phosphorylation of glycine receptor \u03b13 controls breathing in mice.","volume":"120","year":"2010","journal-title":"J Clin Invest"},{"key":"R49-20241223","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1523\/JNEUROSCI.0026-06.2006","article-title":"Modulation of respiratory rhythmogenesis by chloride-mediated conductances during the perinatal period.","volume":"26","year":"2006","journal-title":"J Neurosci"},{"key":"R50-20241223","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1113\/jphysiol.1993.sp019562","article-title":"Microenvironment of respiratory neurons in the in vitro brainstem\u2013spinal cord of neonatal rats.","volume":"462","year":"1993","journal-title":"J Physiol"},{"key":"R51-20241223","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2869.1992.tb00033.x","article-title":"Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat.","volume":"1","year":"1992","journal-title":"J Sleep Res"},{"key":"R52-20241223","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pmn.2011.06.008","article-title":"American Society for Pain Management Nursing guidelines on monitoring for opioid-induced sedation and respiratory depression.","volume":"12","year":"2011","journal-title":"Pain Manag Nurs"},{"key":"R53-20241223","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(84)90714-3","article-title":"The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.","volume":"106","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"R54-20241223","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1124\/jpet.104.077669","article-title":"Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: Relationship with 5-HT1A receptor occupancy and kinetic parameters.","volume":"312","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R55-20241223","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/clpt.2009.194","article-title":"Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia.","volume":"87","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R56-20241223","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1476-5381.2008.00001.x","article-title":"Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.","volume":"156","year":"2009","journal-title":"Br J Pharmacol"},{"key":"R57-20241223","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1476-5381.2010.00738.x","article-title":"Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.","volume":"160","year":"2010","journal-title":"Br J Pharmacol"}],"container-title":["Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.asahq.org\/anesthesiology\/article-pdf\/122\/2\/424\/267207\/20150200_0-00031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/anesthesiology.pubs.asahq.org\/article.aspx?volume=122&page=424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:16:31Z","timestamp":1784898991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/ALN.0000000000000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/aln.0000000000000490","relation":{},"ISSN":["0003-3022"],"issn-type":[{"value":"0003-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}